e-Drug3D

700

CANDESARTAN CILEXETIL


INN
CANDESARTAN CILEXETIL

(has an active metabolite)

cas 145040-37-5
CLASS

CARDIOVASCULAR
ANTIHYPERTENSIVE
HYDROLYZED TO CANDESARTAN DURING ABSORPTION FROM THE GASTROINTESTINAL TRACT
CANDESARTAN IS A SELECTIVE AT1 SUBTYPE ANGIOTENSIN II RECEPTOR ANTAGONIST
CANDESARTAN BLOCKS THE VASOCONSTRICTOR AND ALDOSTERONE-SECRETING EFFECTS OF ANGIOTENSIN II

ROUTE (list)

ORAL

ATC code

C10BX19
C09CA06
C09DB07
C09DA06
C09DX06
C09DX09

PK parameters

Solubility

PRACTICALLY INSOLUBLE IN WATER


Target

TARGET ANGIOTENSIN II RECEPTOR AT1

DrugCentral

Type-1 angiotensin II receptor UNIPROT P30556 AGTR1

Download SDF file 2-ethoxy-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylic acid

Formula:
C33H34N6O6

Calculated chemical properties:

MW 610.66
NB_atoms 45
XLogP 6.32
PSA 105.021
NB_HD 1
NB_HA 12
fsp3 0.33
Lipinski(0=no;1=yes) 0

FDA
NDA 020838 (label) INN (CANDESARTAN CILEXETIL) ATACAND (ANI PHARMS) APPROVAL= AP YEAR= 1998
NDA 021093 (label) INN (CANDESARTAN CILEXETIL ; HYDROCHLOROTHIAZIDE) ATACAND HCT (ANI PHARMS) APPROVAL= AP YEAR= 2000
NDA 090434 (pdf not found) INN (CANDESARTAN CILEXETIL) CANDESARTAN CILEXETIL (MATRIX LABS LTD) APPROVAL= TA YEAR= 2011 OBSOLETE
NDA 090704 (pdf not found) INN (CANDESARTAN CILEXETIL ; HYDROCHLOROTHIAZIDE) CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE (PHARMOBEDIENT) APPROVAL= AP YEAR= 2012
NDA 200887 (pdf not found) INN (CANDESARTAN CILEXETIL ; HYDROCHLOROTHIAZIDE) CANDESARTAN CILEXETIL; HYDROCHLOROTHIAZIDE (TEVA PHARMS USA) APPROVAL= TA YEAR= 2012
NDA 202884 (pdf not found) INN (CANDESARTAN CILEXETIL ; HYDROCHLOROTHIAZIDE) CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE (APOTEX INC) APPROVAL= AP YEAR= 2012 DISCONTINUED
NDA 078702 (pdf not found) INN (CANDESARTAN CILEXETIL) CANDESARTAN CILEXETIL (MYLAN) APPROVAL= AP YEAR= 2013
NDA 202965 (pdf not found) INN (CANDESARTAN CILEXETIL ; HYDROCHLOROTHIAZIDE) CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE (SENORES PHARMS) APPROVAL= AP YEAR= 2013
NDA 202079 (pdf not found) INN (CANDESARTAN CILEXETIL) CANDESARTAN CILEXETIL (APOTEX) APPROVAL= AP YEAR= 2014 DISCONTINUED
NDA 204100 (pdf not found) INN (CANDESARTAN CILEXETIL ; HYDROCHLOROTHIAZIDE) CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE (MACLEODS PHARMS LTD) APPROVAL= AP YEAR= 2015
NDA 203813 (pdf not found) INN (CANDESARTAN CILEXETIL) CANDESARTAN CILEXETIL (MACLEODS PHARMS LTD) APPROVAL= AP YEAR= 2016
NDA 209119 (pdf not found) INN (CANDESARTAN CILEXETIL) CANDESARTAN CILEXETIL (ALEMBIC) APPROVAL= AP YEAR= 2017
NDA 091390 (pdf not found) INN (CANDESARTAN CILEXETIL) CANDESARTAN CILEXETIL (ZYDUS LIFESCIENCES) APPROVAL= AP YEAR= 2017
NDA 203466 (pdf not found) INN (CANDESARTAN CILEXETIL ; HYDROCHLOROTHIAZIDE) CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE (ZYDUS LIFESCIENCES) APPROVAL= AP YEAR= 2017
NDA 207455 (pdf not found) INN (CANDESARTAN CILEXETIL ; HYDROCHLOROTHIAZIDE) CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE (PRINSTON INC) APPROVAL= AP YEAR= 2018
NDA 210302 (pdf not found) INN (CANDESARTAN CILEXETIL) CANDESARTAN CILEXETIL (ALEMBIC) APPROVAL= AP YEAR= 2018
NDA 206233 (pdf not found) INN (CANDESARTAN CILEXETIL) CANDESARTAN CILEXETIL (PRINSTON INC) APPROVAL= AP YEAR= 2023

Other links:

PubChem
ChemicalProbes

U.S. repository of Clinical Trials

VigiAccess
SIDER side effects

ChemSynthesis
Patent@SureChEMBL